Cannabidiol (CBD) is one of the phytocannabinoids found in the cannabis plant. According to multiple scientific and medical sources, CBD has important medical benefits. Since 2013, the National Institutes of Health (PubMed) service has included over 1,100 studies on CBD in its index.
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder. Alembic Pharmaceuticals Ltd., Hetero Labs Ltd., Teva Pharmaceuticals and Torrent Pharmaceuticals Ltd. have received FDA approval to market generic aripiprazole in multiple strengths and dosage forms.
Aripiprazole (Abilify Â® ; Bristol-Myers Squibb) is available in 5, 10, 15, 20, and 30 mg tablets. In adults, the recommended starting dose of aripiprazole for the treatment of schizophrenia is 10 to 15 mg given once daily.After two weeks, the dose may be increased to as much as 30 mg/day as needed. In patients with bipolar disease, the usual dose is 30 mg given once daily.n adults, the recommended starting dose of aripiprazole for the treatment of schizophrenia is 10 to 15 mg given once daily. After two weeks, the dose may be increased to as much as 30 mg/day as needed.